
Medical Economics Pulse, Feb. 26, 2025: Misconceptions about primary care spending, FDA clears new diabetes tech, challenges of performance-based pay
Medical Economics Pulse is a quick-hitting news podcast that keeps busy physicians in the know. Here are your headlines for February 26, 2025.
Hello and welcome to Medical Economics Pulse, a quick-hitting news podcast that keeps busy physicians in the know. We offer concise updates on the most important developments affecting your practice, your bottom line, and the broader health care landscape, delivered to you by our editorial team at Medical Economics.
It’s February 26, 2025, and here are today’s headlines:
First off, a new study reveals that the public
Next up, in a significant step forward for diabetes management, the FDA has cleared Tandem Diabetes Care’s Control-IQ+ technology for use in Type 2 diabetes. Previously approved for Type 1 diabetes,
Finally, a new study links
And that’s it for today’s Medical Economics Pulse. Be sure to subscribe for new episodes, and read more health business news and expert content at MedicalEconomics.com. Be sure to subscribe to our premiere podcast, “Off the Chart, A Business of Medicine Podcast,” which features lively and informative conversations with health care experts, opinion leaders, and practicing physicians about the challenges facing doctors and medical practices.
Thanks for tuning in.
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.















